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Structural Thermodynamics and Kinetics of the Cardiac Myosin/Ome-
camtiv Mecarbil Complex Revealed by Time-Resolved FRET
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We are investigating the structural thermodynamics and kinetics of cardiac
myosin in the presence of omecamtiv mecarbil (OM), a small molecule that
is currently in clinical trials for treating heart failure. AM has been shown to
increase thin-filament activated cardiac myosin ATPase activity, the apparent
rate constant for actin-activated phosphate release from cardiac myosin, and
contractility in the heart (Malik et al, Science 2011). HowOMmodulates theses
activities remains poorly understood. Based on a published Biophysical Society
Annual Meeting poster abstract (Liu et al. Biophys. J. 2013) and on published
studies (Malik et al, Science 2011), we hypothesized that OM stabilizes the pre-
powerstroke structural state in the presence of ATP analogs and increases the
observed rate constant for the actin-activated powerstroke during actin-
activated single ATP turnover. To test these predictions, we used a time-
resolved FRET biosensor of b-cardiac myosin, which detects the mole faction
of pre and post-powerstroke structural states of the myosin light-chain binding
domain, to determine the apparent equilibrium constant for the recovery-stroke
under saturating ADP, ADP.BeF, ADP.AlF and ADP.V nucleotide states in the
presence of saturating OM or DMSO. We varied the temperatures of these ex-
periments to determine whether OM changes the structural thermodynamics of
the pre-powerstroke state. In a second set of experiments, we directly measure
light-chain domain rotation during ATP binding to myosin and during actin
binding to myosin in the presence of ATP. Taken together, these results address
two of the key phenotypes that the drug exhibits in vitro, increased actin-
activated phosphate release, and increased thin-filament activated steady-
state ATPase cycling.
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Impact of Omecamtiv Mecarbil on Human b-Cardiac Myosin Structure
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Contractile dysfunction is a major problem in systolic heart failure and beta-
cardiac myosin provides the driving force for ventricular contraction in hu-
mans. The small molecule drug Omecamtiv Mecarbil (OM) specifically targets
cardiac myosin and is known to enhance cardiac muscle force generation,
while it is unclear how it impacts the structural properties of this motor. We
expressed and purified human b-cardiac myosin subfragment 1 (M2B-S1) by
generating recombinant adenovirus and infecting C2C12 embryonic muscle
cells. We demonstrate that the maximum actin-activated ATPase activity of
M2B-S1 is slowed 7-fold in the presence of 10 mM OM, while the actin con-
centration at which the ATPase activity is one-half maximal (KATPase) was
reduced dramatically (15-fold). The ATPase activity was less ionic strength
dependent in the presence of OM. We observed a concentration-dependent
inhibition of actin filament sliding velocity in the in vitro motility assay. We
generated another M2B-S1 construct that contained a tetracysteine site in
the upper 50 kDa domain (U50), which enables site-specific labeling of the
fluorescein biarscenical hairpin-binding dye (FlAsH). The conformation of
the U50 domain was examined by fluorescence resonance energy transfer
(FRET) as a function of temperature, using deacADP bound to the active
site (donor) and U50 FlAsH (acceptor). When comparing the low (10C)
and high (35C) temperature FRET, the presence of OM resulted in an increase
in the range distances, suggesting the U50 domain is more flexible in the pres-
ence of OM. Our results suggest that OM dramatically enhances the affinity for
actin which results in an increased duty ratio. The structural impact on the flex-
ibility of the U50 domain may enhance the coupling between the nucleotide
and actin binding regions and stabilize the actomyosin.ADP state with high
actin and ADP affinity.
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University, San Diego, CA, USA.Numerous myosin-based myopathies have been identified without a detailed
understanding of their molecular basis. To pursue mechanistic investigations,
we generated transgenic Drosophila expressing the R146N or R249Q myosin
mutations that cause hypertrophic cardiomyopathy in humans. Our studies
show severely compromised flight ability in homozygotes, with an age-
dependent worsening of muscle function and myofibrillar disarray in the indi-
rect flight muscle ultrastructure. The R146N mutation caused an increase in
basal Ca-ATPase andMg-ATPase activities, with a significant decrease in actin
motility. Semi-automated optical heartbeat analysis performed using high-
speed movies of semi-intact mutant heterozygous hearts indicated restrictive
cardiac physiology and diastolic dysfunction. Based upon molecular modeling,
we predict 1) the R146Nmutation alters ionic interaction of the N-terminal mo-
tor domain with E774 of the lever arm, resulting in failure of the lever arm to
cock prior to the power-stroke; and 2) the R249Q mutation disrupts electro-
static interaction with D262 of the central b-sheet domain, interrupting
communication between the ATP-binding and actin-binding sites. Thus, the
models imply that these conserved charge interactions are critical for myosin
function. To test these predictions, lines expressing R146E, E774R, R249D
and D262R mutations, as well as putative suppressor lines R146EþE774R
and R249DþD262R, will be studied using an integrative biochemical, biophys-
ical and physiological approach. Transgenic Drosophila expressing either
R146E or R249D myosin revealed more severe phenotypes relative to cardio-
myopathy mutations. Both homozygous mutants displayed flightless pheno-
types and highly compromised myofibrillar ultrastructure, with the R146E
mutants showing increased basal Ca-ATPase and Mg-ATPase activities, and
no actin motility. Heterozygotes present with severe restricted cardiac
physiology and diastolic dysfunction. Overall our studies indicate that the
Drosophila is a valuable tool to test significant myosin interactions during
health and disease. Supported by NIH R01GM32443 to SIB.
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Effects of Hypertrophic Cardiomyopathy Causing R403Q Mutation on
Human Beta-Cardiac Myosin Biomechanical Function: Single Molecule
to Ensemble Studies
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Over 300 known mutations in human beta-cardiac myosin, the motor that
powers ventricular contraction, causes familial hypertrophic cardiomyopathy
(HCM) by altering the functional capacity of the cardiac sarcomere. The pre-
cise mechanism(s) by which these point mutations alter cardiac function and
lead to the clinically diverse HCM phenotypes is not well understood. The hu-
man heart is optimally designed to cyclically contract under varying loads and
it is likely that the mutations in beta-cardiac myosin affect the power output of
the heart by either altering force, velocity of contraction, or both, which ulti-
mately results in the observed clinical phenotypes.
Using ensemble in vitro motility experiments and single molecule force spec-
troscopy, we show that a truncated version (1-808 aa, containing human ELC)
of human beta-cardiac HCM-causing R403Q myosin mutant has ~15% lower
unitary force generated by a single head but has ~15% higher unloaded velocity
of contraction with pure actin. However, when studied with the six-component
regulatory thin filament (RTF) system (containing tropomyosin and the
troponin complex) the unloaded velocity of R403Q is unchanged. Loaded in vi-
tro motility measurements with both pure actin and RTFs indicate lower
ensemble force and therefore possibly lower power generated by this molecule.
Additional data suggests that R403Q myosin may have lower affinity for RTFs
than WT myosin, signifying a change in the duty ratio. Current efforts
exploring the effects of the R403Qmutation with a two-headed HMM construct
are underway.
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HCM is characterized by thickening of left ventricular wall and interventricular
septum, with abnormalities in contractile functions. It has been thought that
Tm’s flexible association with actin is important for its function. With in vitro
motility assays, we investigated a-Tmmutants V95A and D175N (based on hu-
man sequence), which are known to cause HCM. Reconstituted thin filaments
with rabbit skeletal actin and Tn were placed on HMM-coated glass surface. At
the room temperature (24C), we applied a microscopic heat pulse by focused
446a Tuesday, February 10, 2015laser beam, which momentarily generated a concentric temperature gradient
with the center reaching 50C. Because the pulse duration was brief (2 s),
this procedure did not denature proteins. This area was viewed in a microscope
field, which allowed observations of gliding thin filaments at different temper-
atures in the same field. We found that the gliding occurred on elevating the
temperature even in the absence of Ca (Oyama et al., BBRC, 2012; see also Ish-
iwata, BBA, 1978). The thermally-activated association of HMM to actin re-
sults in a temporary opening of the thin filament, where it is likely that Tm/
Tn is partially dissociated from the actin filament, which causes a partial acti-
vation of the thin filament. We found that the thin filament reconstituted with
V95Awas more difficult to become thermally activated at around physiological
temperature than that with WT or D175N. This result suggests that the critical
temperature for activation is higher for V95A than WT and D175N. These re-
sults further suggest that the thermal stability of the association of V95A Tm to
the actin filament is higher than that of WT Tm. Our results indicate that extra
stability of the actin-Tm association may cause HCM.
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Peptide Modulation of Myosin Coiled Coil Stability Monitored with
Optical and Force Spectroscopy
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The structural impact of hypertrophic cardiomyopathy mutations on the myosin
subfragment-2 are investigated including the coiled coil’s susceptibility to
force and alpha-helical content. The gravitational force spectrometer can mea-
sure the reversible unfolding of the myosin coiled coil under piconewton and
subpiconewton forces. This exquisite sensitivity has enabled the measurement
of the force-induced uncoiling of chemically synthesized peptides of human
cardiac myosin subfragment-2 and the effects of a highly lethal form of hyper-
trophic cardiomyopathy mutation (del930). Because each one of the two syn-
thetic peptides of the coiled coil are covalently attached to opposing surfaces
before forming the coiled coil, it is possible to investigate heterodimers as
well as homodimers containing hypertrophic cardiomyopathy mutations. Initial
results indicate that an order of magnitude more force is required to uncoil the
wild type sequence compared to the homodimer, while the heterodimer needs
only about twice as much force as the homodimer to uncoil. The shapes of the
reversible force distance curves are similar in all three conditions. Furthermore,
the addition of a short positively charged poly-D-lysine peptide that can bind
to the negatively charged glutamate side chains on the peptides strongly
increased the amount of required force for uncoiling myosin. Similar results
were obtained by optical spectroscopy of the alpha-helical content of myosin
synthetic peptides. Based on changes in peptide bond absorbance between
the random coil and alpha helix, it is estimated that the del930 mutation
decreased alpha helical content relative to wild type. The addition of poly-D-
lysine peptide increased the alpha helical content of both wild type and mutant
peptides. These results suggest that it might be possible to use targeted syn-
thetic peptides to reverse some structural effects of certain hypertrophic cardio-
myopathy mutations.
2243-Pos Board B380
Enhanced Troponin-I Binding Explains the Functional Changes Produced
by the Hypertrophic Cardiomyopathy A8V Mutation of Cardiac
Troponin-C
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Our modeling supports a simple molecular mechanism underlying functional
changes in hearts that carry the hypertrophic cardiomyopathy A8V mutation
of troponin-C (TnCA8V). Hypertrophy is commonly observed in hearts carrying
sarcomeric protein mutations that render the regulatory mechanism more sen-
sitive to Ca2þ. Indeed, cardiac muscle fibers reconstituted with TnCA8V require
~2.3 fold less [Ca2þ] to achieve 50% maximum tension compared with con-
trols. In the tertiary structure of TnC, alanine 8 is a conserved residue located
in the N-helix situated between the EF hand that binds Ca2þ and the hydropho-
bic patch that binds the switch peptide of troponin-I (TnIsp). In binding assays,
Ca2þ and TnIsp each have higher affinity for TnCA8V, i.e. ~1.7 and ~1.6 fold
higher respectively compared with control. But, because the largest difference
in Ca2þ affinity is measured only when TnCA8V is reconstituted with the other
thin filament proteins and myosin heads, we model the mutation as having no
direct effect on Ca2þ coordination. Given the affinity for TnIsp as the only
adjustable parameter, we obtain the best fits of the tension data if the affinity
for TnIsp is made ~1.5 fold higher for TnCA8V compared with control, which
coincides with the binding measurement. We also report reconstituted myofi-
brillar ATPase assays that support the hypothesis of stronger peptide bindingwhen the Ca2þ concentration is high, although the predicted enhancement at
low Ca2þ was absent or too small to measure. Possible subtle effects of the mu-
tation on Ca2þ coordination notwithstanding, results of modeling suggest that
the functional phenotype of the A8Vmutation is a consequence of altered inter-
action between TnIsp and TnCA8V. Supported by NIH HL103840 (JRP)
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A compact model of cardiac sarcomere dynamics is useful when developing in-
tegrated models of whole ventricular function. Kinetic models can be simplified
by separating slower from faster processes. The representation of faster pro-
cesses can then be reduced to their equivalent equilibrium relationships. Anal-
ysis of cooperativity within a cardiac sarcomere is also aided by dealing with
equilibria, which can be analyzed using statistical thermodynamics. These prin-
ciples guided the formulation of a compact kinetic model of cardiac sarcomere
dynamics. In this scheme there were three slower processes: (1) reversible tran-
sitions between weak and strong crossbridges, (2) detachment of strong cross-
bridges, (3) dissociation of calcium from regulatory units (RUs) having a strong
crossbridge. In the overall kinetic scheme, an individual RU could exist in 6
states: 3 states of crossbridge binding (none, weak, strong) interacting with 2
states of calcium binding (yes, no). Exchanges between the 4 states without
strong crossbridges occurred by rapid equilibria. Thus, in the reduced model
only 3 kinetic states remained: (1) strong crossbridges attached to RUs where
calcium was bound, (2) strong crossbridges remaining attached even after cal-
cium had dissociated, (3) the equilibrium mixture of the 4 remaining states.
Since strong crossbridges appear to act independently, rate constants between
these 3 states were considered independent of neighboring RUs. However,
cooperativity between neighboring RUs exerted major impacts on the mixture
of 4 states interacting rapidly as equilibria. Applying the linear Ising Model
of statistical thermodynamics, the grand partition function characterizing inter-
actions between neighboring RUs included activating effects from strong
crossbridges as well as free calcium ions. This model predicted steady-state
relationships between force and pCa (given as Hill plots) that reproduced
the experimentally observed bend toward less cooperative slope near half
activation.
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Point mutations found on myofibrillar proteins have been shown to affect
muscle contractility and lead to cardiomyopathies and skeletal muscle disease
syndromes of varying severity. Over 30 mutations localize to residues on the
actin-tropomyosin interface and modify the actin-tropomyosin energy land-
scape, influence tropomyosin positioning on actin, and perturb allosteric
cooperativity between actin, tropomyosin, troponin and myosin. Here, energy
landscape computation, in combination with known actin-tropomyosin
sequence and structural information was used prospectively to identify poten-
tial effects of post-translational modifications generated to rescue regulatory
imbalances. For instance, our interaction energy calculations show that
HCM-associated E62Q tropomyosin mutation weakens residue-residue specific
actin-tropomyosin binding. We then predicted that phosphorylation of neigh-
boring S61 would rescue the deficit, which was corroborated by further energy
landscape determination. To validate these in silico results experimentally,
the sliding velocity of tropomyosin-troponin decorated thin filaments was
measured as a function of added calcium for thin filaments containing the
E62Q, phosphomimetic S61D and E62Q-S61D mutant tropomyosins. In vitro
motility assays showed actin associated with E62Q mutant tropomyosin re-
quires lower Ca2þ to fully activate troponin-tropomyosin regulated mutant fil-
aments when compared to activation of wild-type filaments (as expected from
earlier reports based on acto-S1 ATPase work). In contrast, the double mutant
E62Q-S61D restores Ca2þ-sensitivity toward normal while slightly reducing
sliding velocity. Thus, the shift in Ca2þ-sensitivity by E62Q and subsequent
reversal by S61D parallel the blocked-state phosphorylation-dependent stabili-
zation of actin-tropomyosin noted by our landscape measurements. Likewise, a
decrease in Ca2þ-sensitivity produced by the single mutant S61D alone likely
resulted from blocked site stabilization. Hence, shifts observed in pCa50 for the
mutant tropomyosins could be accurately predicted by in silico calculation of
